Wolverine Stack

The Wolverine Stack is a single vial that combines BPC-157 with TB-500, a synthetic 7-amino-acid fragment of thymosin beta-4. It is used as a once-daily subcutaneous injection during a recovery cycle.

Patients who pick this stack over BPC-157 alone usually have a more aggressive timeline or a more stubborn tissue issue. The argument for pairing is that BPC-157 and TB-500 act on different but overlapping repair pathways. BPC-157 has been studied for tendon, ligament, and gut tissue, mostly in animals. TB-500 acts as a G-actin-sequestering peptide and has been associated with cell migration, angiogenesis, and tissue revascularization, again mostly in preclinical work.

There is no published peer-reviewed literature on this exact two-peptide combination. The individual evidence for each peptide is animal-heavy. There is no completed published human efficacy trial for either. We talk honestly about that picture before starting.

We dose near the area of concern when it’s reasonable to do so. Local exposure appears to matter in the animal work, and clinical practice has followed that.

Cycle length is matched to the issue. A recent strain might run 4 weeks. A persistent tendinopathy or post-surgical recovery might run 8 weeks, with a break before deciding whether to repeat.

Two things to be clear about. There is no published study on this exact two-peptide combination, and there is no completed published human efficacy trial for either component. Both BPC-157 and TB-500 are on prohibited substance lists for tested athletes (USADA, WADA). We don’t recommend this protocol for anyone subject to drug testing.

Recovery work often pairs with skin and aesthetic services around procedure timelines. This protocol is often used to supplement other services like SkinPen microneedling, RF microneedling, and our laser series.